Next Article in Journal
The Changing Epidemiology of Kunjin Virus in Australia
Previous Article in Journal
Effects of Habitual Anger on Employees’ Behavior during Organizational Change
Previous Article in Special Issue
Strategies to Minimize Antibiotic Resistance
Article Menu

Export Article

Open AccessReview
Int. J. Environ. Res. Public Health 2013, 10(12), 6235-6254; doi:10.3390/ijerph10126235

Escherichia coli in Europe: An Overview

Department of Experimental and Clinical Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti I-66013, Italy
Department of Cell Biology and Neuroscience, University of South Alabama, Mobile, AL 36688, USA
Author to whom correspondence should be addressed.
Received: 15 September 2013 / Revised: 4 November 2013 / Accepted: 7 November 2013 / Published: 25 November 2013
(This article belongs to the Special Issue Antimicrobial Resistance Prevention and Control)
View Full-Text   |   Download PDF [236 KB, uploaded 19 June 2014]


Escherichia coli remains one of the most frequent causes of several common bacterial infections in humans and animals. E. coli is the prominent cause of enteritis, urinary tract infection, septicaemia and other clinical infections, such as neonatal meningitis. E. coli is also prominently associated with diarrhoea in pet and farm animals. The therapeutic treatment of E. coli infections is threatened by the emergence of antimicrobial resistance. The prevalence of multidrug-resistant E. coli strains is increasing worldwide principally due to the spread of mobile genetic elements, such as plasmids. The rise of multidrug-resistant strains of E. coli also occurs in Europe. Therefore, the spread of resistance in E. coli is an increasing public health concern in European countries. This paper summarizes the current status of E. coli strains clinically relevant in European countries. Furthermore, therapeutic interventions and strategies to prevent and control infections are presented and discussed. The article also provides an overview of the current knowledge concerning promising alternative therapies against E. coli diseases. View Full-Text
Keywords: Escherichia coli; Gram-negative bacteria; pathotype; multidrug resistance; epidemiology; phage therapy; antimicrobial peptides; combination therapy Escherichia coli; Gram-negative bacteria; pathotype; multidrug resistance; epidemiology; phage therapy; antimicrobial peptides; combination therapy
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Allocati, N.; Masulli, M.; Alexeyev, M.F.; Di Ilio, C. Escherichia coli in Europe: An Overview. Int. J. Environ. Res. Public Health 2013, 10, 6235-6254.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top